Daehan New Pharm Co. Ltd (054670) — Long-term Investment Intensity

Latest as of September 2018: 26.2%

Daehan New Pharm Co. Ltd (054670) has a Long-term Investment Intensity of 26.2% as of September 2018. Long-term investments of ₩30.87 Billion represent 26.2% of total assets of ₩117.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Daehan New Pharm Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

26.2%
LT Investments / Total Assets

Long-term Investments

₩30.87 Billion
KRW

Total Assets

₩117.93 Billion
KRW

Country

Korea
KQ

Daehan New Pharm Co. Ltd Long-term Investment Intensity (2014–2017)

This chart shows how Daehan New Pharm Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of September 2018, the intensity stands at 26.2%, reflecting long-term investments of ₩30.87 Billion against total assets of ₩117.93 Billion KRW. For the complete balance sheet picture, see 054670 total assets.

Annual Long-term Investment Intensity for Daehan New Pharm Co. Ltd (2014–2017)

The table below presents the year-by-year Long-term Investment Intensity for Daehan New Pharm Co. Ltd from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Daehan New Pharm Co. Ltd carry for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2017 27.2% ₩33.09 Billion ₩121.82 Billion ▲ +1.2 pp
2016 25.9% ₩33.88 Billion ₩130.72 Billion ▼ -8.4 pp
2015 34.3% ₩45.53 Billion ₩132.63 Billion ▼ -0.8 pp
2014 35.1% ₩45.83 Billion ₩130.47 Billion
pp = percentage points